BVS Q3 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$581M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$109M+26.8% YoY

Gross Profit

$79M72.6% margin

Operating Income

-$1M-1.0% margin

Net Income

-$1M-1.0% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$9M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$655M

Total Liabilities

$424M

Stockholders' Equity

$153M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$109M	$86M	+26.8%
Gross Profit	$79M	$62M	+26.6%
Operating Income	-$1M	$7M	-115.1%
Net Income	-$1M	$8M	-112.7%

Revenue Segments

Pain Treatments And Joint Preservation

$61M56%

Restorative Therapies

$30M28%

Bone Graft Substitutes

$18M16%

Geographic Segments

UNITED STATES

$99M91%

Non-US

$10M9%